All Stories

  1. Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1
  2. Synthesis, Spectroscopic Characterization, Drug‐Likeness, and Antibacterial Activity of a Novel Triazole Derivative
  3. Abstract Th0089: Targeting Oxalate Overproduction: From Rare Genetic Disorders to Common Cardiometabolic Diseases
  4. Molecular dynamics, docking and quantum calculations reveal conformational changes influenced by CYP271A amino acid mutations related to cerebrotendinous xanthomatosis
  5. Solvation effects, structural, vibrational analysis, chemical reactivity, nanocages, ELF, LOL, docking and MD simulation on Sitagliptin
  6. Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway
  7. Synthesis, Solvent effects, Chemical reactivity, Molecular Docking and Molecular Dynamic Studies of Triazole derivative
  8. Editorial: Use of computational tools for designing epigenetic drugs
  9. Molecular insight into endosulfan degradation by Ese protein from Arthrobacter: Evidence‐based structural bioinformatics and quantum mechanical calculations
  10. Design and simulation of a caprylic acid enzymatically modified phosphatidylcholine micelle using a coarse-grained molecular dynamics simulations approach
  11. Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations
  12. Synthesis, characterization, molecular docking and molecular dynamics simulations of benzamide derivatives as potential anti-ovarian cancer agents
  13. An investigation on the molecular structure, interaction with metal clusters, anti-Covid-19 ability of 2-deoxy-D-glucose: DFT calculations, MD and docking simulations
  14. HDAC Inhibition as Neuroprotection in COVID-19 Infection
  15. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6
  16. Dihydropyrazole-Carbohydazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the Hdac6
  17. Synthesis, spectroscopic characterization, molecular docking studies and DFT calculation of novel Mannich base 1-((4-ethylpiperazin-1-yl)(2-hydroxyphenyl)methyl)naphthalen-2-ol
  18. In silico design of HDAC6 inhibitors with neuroprotective effects
  19. Computational study of DMPC liposomes loaded with the N-(2-Hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and determination of its antiproliferative activity in vitro in NIH-3T3 cells
  20. Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells
  21. Drug repositioning Nsp15 of SARS-COV-2 for treatment of Covid-19
  22. Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population
  23. Docking Approaches Used in Epigenetic Drug Investigations
  24. N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
  25. Structural insights into spike protein and its natural variants of SARS-CoV-2 found on Mexican population.
  26. DNA methylation of the RE-1 silencing transcription factor in peripheral blood mononuclear cells and gene expression of antioxidant enzyme in patients with late-onset Alzheimer disease
  27. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
  28. O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity
  29. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach
  30. Identification of the NADP+ Structural Binding Site and Coenzyme Effect on the Fused G6PD::6PGL Protein from Giardia lamblia
  31. Vorinostat, a possible alternative to Metronidazole for the treatment of amebiasis caused by Entamoeba histolytica.
  32. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6
  33. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
  34. Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells
  35. Searching the conformational complexity and binding properties of HDAC6 through docking and molecular dynamic simulations
  36. Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies
  37. Three Amino Acid Derivatives of Valproic Acid: Design, Synthesis, Theoretical and Experimental Evaluation as Anticancer Agents